SK Bioscience Co.,Ltd (에스케이바이오사이언스(주))
KOSPI Stock Code: 302440 | DART Corp Code: 01319899
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | SK Bioscience Co.,Ltd |
|---|---|
| Korean legal name | 에스케이바이오사이언스(주) |
| Alternate names | SK바이오사이언스 |
| Market | KOSPI |
| Stock Code | 302440 |
| DART Corp Code | 01319899 |
| CEO | 안재용 |
| Business Registration No. | 8188600991 |
| Corporate Registration No. | 1311110523736 |
| Established Date | 2018-07-01 |
| Fiscal Month | 12 |
| KSIC Industry Code | 211 |
| Address (KO) | 인천광역시 연수구 연구단지로 38 - |
| Homepage | https://www.skbioscience.com/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260313000936 |
| verified_at | 2026-11-01T02:27:10.203Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260313000936
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 651,368,342,533 | KRW 267,545,049,154 |
| Operating Income (영업이익) | KRW -123,501,682,766 | KRW -138,431,298,006 |
| Net Income (당기순이익) | KRW -56,173,210,192 | KRW -50,117,070,464 |
| Total Assets (자산총계) | KRW 2,955,743,509,068 | KRW 2,843,596,036,892 |
| Total Liabilities (부채총계) | KRW 918,289,306,349 | KRW 821,143,859,318 |
| Total Equity (자본총계) | KRW 2,037,454,202,719 | KRW 2,022,452,177,574 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-26 | 20261026800481 | Organization of Investor Relations Event | 기업설명회(IR)개최(안내공시) | SK바이오사이언스 |
2026-08-28 | 20260828001235 | Disclosure of Current Status of Large-scale Business Groups [Quarterly Disclosure (For individual company)] | 대규모기업집단현황공시[분기별공시(개별회사용)] | SK바이오사이언스 |
2026-08-14 | 20260814002309 | Matters concerning payment amount for each payment method-payment period and Dispute Resolution Organization | 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항 | SK바이오사이언스 |
2026-08-13 | 20260813001292 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | SK바이오사이언스 |
2026-08-10 | 20260810800485 | Organization of Investor Relations Event | 기업설명회(IR)개최(안내공시) | SK바이오사이언스 |
2026-08-10 | 20260810800429 | Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) | 연결재무제표기준영업(잠정)실적(공정공시) | SK바이오사이언스 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260313000936 | verified_at: 2026-11-01T02:27:10.203Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.